arrow
A

Agnė Krilavičiūtė

german cancer research center
H指数:17
被引数:996

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Confirmation of Prostate-specific Antigen (PSA) Values Improves Prostate Cancer Screening in Early Middle-Aged Men – Data from the PROBASE Trial

前列腺特异性抗原(PSA)值确认可改善中年早期男性的前列腺癌筛查——PROBASE试验数据

2026-07-130
OAAI
Risk-adapted Prostate Cancer Screening Achieves Mammography-like Benefits: Evidence and Implications for Europe

风险适应型前列腺癌筛查实现了类似乳腺X光的效益:证据及其对欧洲的影响

2025-12-180
PRE
Value of Additional Systematic Cores During Magnetic Resonance Imaging–guided Targeted Biopsy in Prostate Cancer Screening for Young Men: Results from the PROBASE Trial

在前列腺癌筛查中,MRI引导下靶向活检时增加系统性活检核心的价值:PROBASE试验的结果

2025-11-110
OAAI
Do We Need Early Detection of Grade Group 2 Prostate Cancer in a Screening Program for Young Men? Results from the PROBASE Screening Trial

我们是否需要在针对年轻男性的筛查计划中早期检测Gleason评分组2的前列腺癌?PROBASE筛查试验的结果

2025-07-100
OAAI
Prostate Cancer Detection in Younger Men: A Comparative Analysis of Systematic and Magnetic Resonance Imaging–targeted Biopsy in the PROBASE Trial

年轻男性前列腺癌检测:系统活检与磁共振成像靶向活检的比较分析——PROBASE试验

2025-06-020
OAAI
Characterisation of Multiparametric Magnetic Resonance Imaging of the Prostate in Younger Men with Normal Prostate-specific Antigen Within the PROBASE Study

前列腺多参数磁共振成像在PROBASE研究中的特征分析:年轻且前列腺特异性抗原正常男性群体

2025-05-010
PRE
Worry about prostate cancer and risk perception among middle-aged men: results from the PROBASE trial

担心前列腺癌与风险认知在中年男性中的情况:PROBASE试验的结果

2025-03-050
OA
Risk-adjusted Screening for Prostate Cancer-Defining the Low-risk Group by Data from the PROBASE Trial

风险调整后的前列腺癌筛查—利用PROBASE试验数据定义低风险组

2024-12-010
OAAI
Digital Rectal Examination Is Not a Useful Screening Test for Prostate Cancer
2023-12-0116
PRE
Multiparametric Magnetic Resonance Imaging in Prostate Cancer Screening at the Age of 45 Years: Results from the First Screening Round of the PROBASE Trial
2023-10-0116
OA
Adherence to a risk-adapted screening strategy for prostate cancer: First results of the PROBASE trial

坚持风险适应性前列腺癌筛查策略: PROBASE试验的第一个结果

2022-10-0516
OA